Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
Prostate cancer is the most common malignancy in men. In the present study, LNCaP (androgen-sensitive human prostate cancer cells) and PC-3 cells (androgen-independent human prostate cancer cells) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with arsenic triox...
Main Authors: | Hui-Wen Chiu, Yi-An Chen, Sheng-Yow Ho, Ying-Jan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3282747?pdf=render |
Similar Items
-
Tumor growth inhibition by arsenic trioxide(As203)in the orthotopic metastasis model of androgen-independent prostate cancer
by: Maeda, Hiroshi
Published: (2011) -
QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
by: Vicken Zeitjian, et al.
Published: (2019-01-01) -
Mechanistic study of combination treatment with radiation and arsenic trioxide enhanced antitumor effects in human malignant glioma and sarcoma cells
by: Hui-WenChiu, et al.
Published: (2011) -
Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2015-01-01) -
Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
by: Simeng Wen, et al.
Published: (2020-07-01)